Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05060003
Title Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection
Recruitment Not yet recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications

skin melanoma

Therapies

Atezolizumab

Atezolizumab + Tiragolumab

Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
City of Hope Duarte California 91010 United States Details
University of California - San Francisco San Francisco California 94143 United States Details
Yale School of Medicine New Haven Connecticut 06510 United States Details
Washington University School of Medicine Saint Louis Missouri 63110 United States Details
Memorial Sloan Kettering New York New York 10065 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field